Long COVID – A Pandemic Hidden in Plain Sight
The knowledge gap of not understanding the science of COVID and long COVID will be addressed as Dr. Cluck explains the epidemiology of long COVID. He is a subject matter expert in infectious disease. The therapeutic options for long COVID will be discussed and explained in detail which will provide the needed information to help less experienced healthcare professionals navigate these uncharted seas of the pandemic and its lingering effects.
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
1. Examine the science of COVID
2. Differentiate COVID from long COVID
3. Appraise current epidemiology of long COVID
4. Compare and contrast therapeutic interventions for long COVID
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
1. Differentiate COVID from long COVID
|Helpful Tips for Users - Vizient CE System.pdf||134.81 KB|
|CE Information for Credit - Live_2022.docx||115.67 KB|
David Cluck, PharmD, BCPS, BCIDP, AAHIVP
Associate Professor in the Department of Pharmacy Practice at East Tennessee State University (ETSU) Gatton College of Pharmacy
East Tennessee State University
Jackie Stokes, BS
Manager, Pharmacy Program
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Relevant Financial Relationships:
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
David Cluck, PharmD, BCPS, BCIDP, AAHIVP, speaker for this educational activity, is on the Advisory Board for Astellas.
All relevant financial relationships listed for these individual(s) have been mitigated.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity”
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician